Pertuzumab/trastuzumab in early stage HER2-positive breast cancer: 5-year and final analysis of the BERENICE trial
No Thumbnail Available
Identifiers
Date
2021-05-08
Authors
Dang, C.
Ewer, M. S.
Delaloge, S.
Ferrero, J-M.
Colomer, R.
de la Cruz Merino, L.
Dadswell, K.
Verrill, M.
Eiger, D.
Sarkar, S.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Metrics
Export
